Literature DB >> 19224360

Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes.

Murat Sönmezer1, Aylin Pelin Cil, Cem Atabekoğlu, Sinan Ozkavukçu, Batuhan Ozmen.   

Abstract

PURPOSE: To report two successful antagonist IVF cycles; one ending up with pregnancy despite premature luteinization (case 1, aged 35 years), and the other with the retrieval of high quality oocytes despite premature ovulation (case 2, aged 39 years).
METHODS: Serum LH was 36 and 47 IU/L on cycle day 7 before antagonist administration, which was then brought to 6.94 and 3.92 IU/L by antagonist administration, and kept below these levels throughout the remaining stimulation in case 1 and 2 respectively. Serum progesterone was 1.42 and 5.5 ng/mL on the day of hCG respectively. Ten metaphase II (MII) oocytes were harvested wherein 3 grade A embryos were transferred in case 1, and seven good quality MII oocytes were retrieved wherein six embryos were cryopreserved in case 2.
CONCLUSIONS: More precise cut thresholds for both LH and progesterone are necessary for accurate prediction of the cycle outcomes.

Mesh:

Substances:

Year:  2009        PMID: 19224360      PMCID: PMC2654938          DOI: 10.1007/s10815-009-9299-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  18 in total

1.  Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

Authors: 
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

2.  Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

Authors:  F Olivennes; J Belaisch-Allart; J C Emperaire; H Dechaud; S Alvarez; L Moreau; B Nicollet; J R Zorn; P Bouchard; R Frydman
Journal:  Fertil Steril       Date:  2000-02       Impact factor: 7.329

3.  A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome.

Authors:  U D Gordon; R F Harrison; M Fawzy; B Hennelly; A C Gordon
Journal:  Fertil Steril       Date:  2001-02       Impact factor: 7.329

4.  Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels.

Authors:  Judith A F Huirne; Andre C D van Loenen; Roel Schats; Joseph McDonnell; Peter G A Hompes; Joop Schoemaker; Roy Homburg; Cornelis B Lambalk
Journal:  Hum Reprod       Date:  2004-08-27       Impact factor: 6.918

5.  Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.

Authors:  Ernesto Bosch; Iván Valencia; Ernesto Escudero; Juana Crespo; Carlos Simón; José Remohí; Antonio Pellicer
Journal:  Fertil Steril       Date:  2003-12       Impact factor: 7.329

6.  Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation.

Authors:  R Frydman; C Cornel; D de Ziegler; J Taieb; I M Spitz; P Bouchard
Journal:  Fertil Steril       Date:  1991-11       Impact factor: 7.329

7.  Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.

Authors:  D L Cassidenti; M V Sauer; R J Paulson; E C Ditkoff; J Rivier; S S Yen; R A Lobo
Journal:  Am J Obstet Gynecol       Date:  1991-12       Impact factor: 8.661

8.  Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization.

Authors:  R S Legro; B A Ary; R J Paulson; F Z Stanczyk; M V Sauer
Journal:  Hum Reprod       Date:  1993-09       Impact factor: 6.918

9.  Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

Authors:  J B Engel; M Ludwig; R Felberbaum; C Albano; P Devroey; K Diedrich
Journal:  Hum Reprod       Date:  2002-08       Impact factor: 6.918

10.  Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.

Authors:  Tsung-Hsien Lee; Yu-Hung Lin; Kok-Min Seow; Jiann-Loung Hwang; Chii-Ruey Tzeng; Yu-Shih Yang
Journal:  Fertil Steril       Date:  2007-12-11       Impact factor: 7.329

View more
  8 in total

1.  Two successful pregnancies achieved by converting an in vitro fertilization cycle to an intrauterine insemination cycle in five cases with documented premature ovulation.

Authors:  Kubilay Vicdan; Cem Akarsu; Eran Sözen; Burcu Buluç; Deniz K Üstündağ; Kutay Biberoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

2.  [Effects of cetrorelix versus ganirelix in gonadotropin-releasing hormone antagonist cycles for preventing premature luteinizing hormone surges and on clinical outcomes of IVF-ET cycles].

Authors:  Jun Zhang; Xingyu Zhou; Yingxue Chen; Qingyan Zhang; Ying Li; Jing Zhe; Xin Chen; Shiling Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

3.  Are extremely high progesterone levels still an issue in IVF?

Authors:  V S Vanni; P Viganò; L Quaranta; L Pagliardini; P Giardina; M Molgora; M Munaretto; M Candiani; E Papaleo
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

4.  A Premature Rise of Luteinizing Hormone Is Associated With a Reduced Cumulative Live Birth Rate in Patients ≥37 Years Old Undergoing GnRH Antagonist In Vitro Fertilization Cycles.

Authors:  Fumei Gao; Yanbin Wang; Dan Wu; Min Fu; Qiuxiang Zhang; Yumeng Ren; Zexi Yang; Huan Shen; Hongjing Han
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-02       Impact factor: 5.555

5.  Clinical pregnancy resulting from intracytoplasmic sperm injection of prematurely ovulated oocytes retrieved from the posterior cul-de-sac.

Authors:  Nigel Pereira; Pak H Chung; Isaac Kligman; Zev Rosenwaks
Journal:  F S Rep       Date:  2021-08-18

6.  The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles.

Authors:  Min Hye Choi; Sun Hwa Cha; Chan Woo Park; Jin Young Kim; Kwang Moon Yang; In Ok Song; Mi Kyoung Koong; Inn Soo Kang; Hye Ok Kim
Journal:  Clin Exp Reprod Med       Date:  2013-06-30

7.  Elevated serum progesterone/ MII oocyte ratio on the day of human chorionic gonadotropin administration can predict impaired endometrial receptivity.

Authors:  Abbas Aflatoonian; Robab Davar; Farzaneh Hojjat
Journal:  Iran J Reprod Med       Date:  2014-06

8.  Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.

Authors:  Raffaella Depalo; Paolo Trerotoli; Annarosa Chincoli; Margherita Patrizia Vacca; Giuseppina Lamanna; Ettore Cicinelli
Journal:  Int J Reprod Biomed       Date:  2018-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.